<DOC>
	<DOCNO>NCT01348776</DOCNO>
	<brief_summary>The purpose study determine efficiency Hair2Go device short-term long-term removal unwanted hair adjunctive shave use before-after study design .</brief_summary>
	<brief_title>The Efficiency Hair2Go Device : A Prospective , Open , Label Study With Before-After Design</brief_title>
	<detailed_description>This study multicenter study , design determine efficacy Hair2Go hair removal device compare extent hair removal without maintenance treatment . Preferably , two anatomical region treat select include axilla either leg ( calf ) forearm . The size area treat approximately 5x5 cm2 . Additional area include face treat accord subject 's request PI 's discretion mandatory . Subjects provide device instruct method usage . The subject expect self-administer treatment clinic `` simulate home environment '' . The duration treatment session approximately 30-60 minute . Each select anatomical region ( leave right side ) treat either low , medium , high Elōs energy level accord PI 's discretion . However anatomical region except axilla treat either low medium elōs energy level . Only axilla treat energy 4J//cm2 A defined area 5x5 cm2cm2 leg treat serve reference temporal change hair growth might subject factor , include fluctuation hormone level . Both side ( left right ) anatomical region receive basic treatment . One side receive 3 additional maintenance treatment 4 week interval ( `` Maintenance '' v `` No maintenance '' side ) end experiment . More specifically , study include 11 visit clinic : initial consultation , 7 basic treatment 1 week interval follow one side 3 maintenance treatment , 4 week apart . Follow ups conduct 4 12 week last basic treatment .</detailed_description>
	<criteria>Inclusion Criteria 1 . Healthy male female , 18 65 year age . 2 . Subject Black dark brown terminal hair area treat . 3 . Terminal hair density requirement great 15 hair within hair count site ( 3x3 cm area ) determine manual hair count perform study investigator . 4 . Willing sign inform consent . 5 . Willing follow treatment schedule post treatment followup . 6 . Willingness photograph treat area take may use marketing educational presentation and/or publication 7 . Willingness avoid excessive sun exposure two week prior treatment Exclusion Criteria Skin Hair 1 . Subjects white , red , light brown and/ blonde hair area treat . 2 . A history keloidal scarring ( hypertrophic scar keloid ) . 3 . Active dermatologic lesion infection treatment site . 4 . Subject permanent tattoo makeup treatment area . 5 . Recently tan area treat and/or unable unlikely refrain tan study . 6 . Subject disease related photosensitivity , porphyria , polymorphic light eruption , solar urticaria , lupus , etc 7 . Subject history herpes outbreak area treatment , unless receive preventative treatment physician Other Medical Conditions 8 . Pregnant , plan become pregnant , hormone fluctuation and/or breast feeding experiment . 9 . Subjects Diabetes ( Type I II ) systemic metabolic condition 10 . Subject active electrical implant anywhere body , pacemaker , internal defibrillator , insulin pump , incontinence device , etc . 11 . Subject suffers epilepsy . 12 . Subject active cancer , history skin cancer cancer area treat , include presence malignant premalignant pigment lesion . 13 . Subject receive radiation therapy chemotherapy treatment past 3 month . 14 . Subject know anticoagulative thromboembolic condition form anticoagulation treatment . 15 . Subject history immunosuppressant/immune deficiency disorder ( include HIV infection AIDS ) currently use immunosuppressive medication . 16 . Subject condition physician 's opinion would make unsafe subject treat . Medication/treatments 17 . Subject rotate type tweezer epilator treatment , wax within last 3 week 18 . Subject electrolysis treatment within last 6 month treatment area . 19 . Subject type professional intense pulse light ( IPL ) , laser RF hair removal treatment site within last 6 month . 20 . Subject take medication know induce photosensitivity , include nonsteroidal antiinflammatory agent , tetracycline , phenothiazine , thiazide diuretic , sulfonylurea , sulfonamide , Dacarbazine ( DTIC ) , fluorouracil , vinblastine , griseofulvin within 4 week therapy . 21 . Subject take Accutane® within 6 month therapy . 22 . Subject steroid regimen last three month . 23 . Subject Gold therapy ( arthritis treatment ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>hair reduction</keyword>
	<keyword>hair removal</keyword>
	<keyword>hair clearance</keyword>
</DOC>